SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-000311
Filing Date
2021-06-07
Accepted
2021-06-07 07:17:31
Documents
70
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q impl-20210331.htm   iXBRL 10-Q 2327417
2 EX-3.1 impl-20210331ex3_1.htm EX-3.1 57035
3 EX-3.2 impl-20210331ex3_2.htm EX-3.2 300163
4 EX-31.1 impl-20210331ex31_1.htm EX-31.1 14603
5 EX-31.2 impl-20210331ex31_2.htm EX-31.2 14600
6 EX-32.1 impl-20210331ex32_1.htm EX-32.1 7442
7 EX-32.2 impl-20210331ex32_2.htm EX-32.2 7440
  Complete submission text file 0000950170-21-000311.txt   7761327

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT impl-20210331_lab.xml EX-101.LAB 391528
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT impl-20210331.xsd EX-101.SCH 48690
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT impl-20210331_pre.xml EX-101.PRE 297481
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT impl-20210331_def.xml EX-101.DEF 151801
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT impl-20210331_cal.xml EX-101.CAL 32776
13 EXTRACTED XBRL INSTANCE DOCUMENT impl-20210331_htm.xml XML 1200858
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL NEUROPHARMA INC (Filer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40353 | Film No.: 21998214
SIC: 2834 Pharmaceutical Preparations